Accelerating Research and Development of Next Generation Malaria Vaccines Against Malaria ? A Model for Mosquito-Borne Diseases

The National Institute of Allergy and Infectious Diseases (NIAID) is seeking to support basic research, discovery, and/or preclinical development of highly efficacious vaccines for malaria and potentially other mosquito-borne illnesses. The program will encourage novel approaches to vaccine design that capitalize on recent technological innovations. Some key points about this opportunity include: • The program is focused on developing vaccines for malaria and other mosquito-borne diseases. • The NIAID is encouraging novel approaches to vaccine design, including structure-based immunogen design and combination vaccines. • The opportunity is open to a variety of applicants, including public and state-controlled institutions of higher education, non-profits, and for-profit organizations. • The estimated award date is December 1, 2027.